US Stock MarketDetailed Quotes

Arcutis Biotherapeutics (ARQT)

Watchlist
  • 22.440
  • +0.230+1.04%
Trading Mar 23 10:59 ET
2.78BMarket Cap-172.62P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arcutis Biotherapeutics (ARQT) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
ZORYVE foam181.89M48.37%
ZORYVE cream 0.3%121M32.17%
ZORYVE cream 0.15%68.27M18.15%
Other revenue4M1.06%
ZORYVE cream 0.05%911K0.24%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States376.07M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +50.05%
Sample Name
Sample Code
 +41.56%
Sample Name
Sample Code
 +36.11%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+35.83%
5
United States Gasoline Fund Lp
UGA
+31.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +3.82%
Sample Name
Sample Code
 +3.61%
Sample Name
Sample Code
 +2.48%
4
ASE Technology
ASX
+1.49%
5
Taiwan Semiconductor
TSM
+0.77%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On March 23 Eastern Time, US President Trump stated that 'Very good and productive talks were held with Iran over the past two days, and I h Show More
Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

- No more -